About Us
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Press Centre
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
Our Pages
Language
Financial News
ANNUAL REGULAR ASSEMBLY
Notice of convening annual regular assembly of Bosnalijek joint stock company
Pursuant to Article 230, paragraph (1) of Company Law (Official Gazette of FB&H, No. 81/15) and Article 48, paragraph (1) and (2) of valid Bosnalijek d.d. Statute (consolidated text No: 2830/2017 of 18.09.2017), and based on the Supervisory Board's Decision on Convening Annual Regular Assembly No: 1614/19 of 29.05.2019, we hereby announce:
MORE
PRESS CENTRE / NEWS
Bosnalijek achieves Record Turnover of 107 million BAM in Foreign Markets
Bosnalijek recorded great business results in 2017, further underlining its reputation as the leading pharmaceutical company in Bosnia and Herzegovina (BiH). This is confirmed by achieved sales revenue to the amount of 153 million BAM, which represents an increase of 17 million BAM or 13 per cent in comparison to 2016. Profit before tax was 13 million BAM, an increase of 12 per cent compared to profit generated in 2016.
In detail
PRESS CENTAR / NEWS
Continuous Growth: Bosnalijek Revenue increases by 35 per cent in 2017
During the first ten months of 2017, Bosnalijek revenue increased by 35 per cent compared to the same period in the previous year.
In detail
Previous Announcements
Notification - Proposals of candidates for members of Bosnalijek d.d. Su ...
Notice of Reconvened Annual General Assembly of Bosnalijek d.d.
Annual General Assembly of Bosnalijek d.d. - NOTIFICATIONS
Excellent Sales Results on the Russian Market
Recapitalisation enabled New Investment in and the further Development o ...
Bosnalijek saw Revenue and Profit Increase in 2016
Announcement of the Fifth (V) Issuance of Shares through a Closed Offeri ...
Report on a Development that significantly affects the Financial Operati ...
Bosnalijek makes Record Profit
Report from the Voting Committee – 23 June 2014
Bosnalijek makes a Net Profit of 2 Million BAM